Cargando…
Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials
OBJECTIVE: To investigate the efficacy of rovatirelin, a thyrotropin-releasing hormone analogue, for ataxias in patients with spinocerebellar degeneration (SCD). METHODS: Two multicentre, randomised, double-blind, placebo-controlled phase 3 studies (KPS1301, KPS1305) enrolled patients with predomina...
Autores principales: | Nishizawa, Masatoyo, Onodera, Osamu, Hirakawa, Akihiro, Shimizu, Yoshitaka, Yamada, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035688/ https://www.ncbi.nlm.nih.gov/pubmed/31937586 http://dx.doi.org/10.1136/jnnp-2019-322168 |
Ejemplares similares
-
Doxycycline in early CJD: a double-blinded randomised phase II and observational study
por: Varges, Daniela, et al.
Publicado: (2017) -
Genotype-associated cerebellar profiles in ALS: focal cerebellar pathology and cerebro-cerebellar connectivity alterations
por: Bede, Peter, et al.
Publicado: (2021) -
Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial
por: Charlesworth, Georgina, et al.
Publicado: (2016) -
Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?
por: Kanouchi, Tadashi, et al.
Publicado: (2012) -
Medial temporal lobe epilepsy is associated with neuronal fibre loss and paradoxical increase in structural connectivity of limbic structures
por: Bonilha, Leonardo, et al.
Publicado: (2012)